Ebrahim MostafaviEbrahim Mostafavi has so far received training at Stanford Cardiovascular Institute, Stanford University School of Medicine (PostDoc), Northeastern University (Ph.D.), Harvard Medical School (Researcher), and University of Tehran (M.Sc. and B.Sc.). Hs research interests revolve around the engineering and development of (nano)biomaterials, nanocarriers, and 3D in vitro models (hydrogels, 3D bioprinted constructs, nanofibrous scaffolds, organoids, vascular grafts, and microfluidic systems) to create biologically complex systems for tissue engineering and regenerative medicine, translational medicine, cancer therapy (with focus on women's cancer), biosensing, and infectious diseases. Dr. Mostafavi serves as Associate Editor-in-Chief of several prestigious and high-impact journals within Elsevier, Springer, Cell Press, Dove Medical Press, T&F, Frontiers, etc. He is also an Editorial Board Member of 25+ impactful and prestigious biomedical and materials science journals. His scholarly work comprises >145 publications with an H-index of 27 (i10-index= 71) including papers published in The Lancet family and JAMA Network journals. So far, he has edited several books and also contributed to leading more than 40 introductory book chapters in a very multidisciplinary field of biomedical, biotechnology, nanotechnology, and regenerative/translational medicine. Read More Read Less